​

Funding Round

Series C - UrgentRx

Series C - UrgentRx

Investment Firm

Overview

UrgentRx offers a line of fast-acting, portable over-the-counter medications that provide 'right now' relief for everyday ailments.

Announced Date

Apr 17, 2014

Funding Type

Series C

Highlights

Location

United States, North America

Social

Investor Lead

N/A

Participant Investors

4

Investor Name
Participant InvestorBoulevard Capital Partners
Participant InvestorSam Zell
Participant InvestorDavid Bonderman
Participant InvestorJUMP Investors

Round Details and Background

UrgentRx raised $17500000 on 2014-04-17 in Series C

UrgentRx offers a line of fast-acting, portable over-the-counter medications that provide 'right now' relief for everyday ailments.

Company Funding History

6

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Oct 29, 2013
Venture Round - UrgentRx
-2.0M
Apr 02, 2013
Series B - UrgentRx
4-2.7M
Jun 30, 2012
Series B - UrgentRx
-3.0M
Dec 01, 2010
Series A - UrgentRx
-1.6M

Recent Activity

There is no recent news or activity for this profile.